Fanconi Anemia

Pathogenesis and Characteristic Clinical Features

Fanconi anemia presents as a complex mix of congenital physical abnormalities, bone marrow failure and progression to cancer:

• Characteristic Skin and Mucosal Findings:
  • Café-au-lait macules (CALMs): Present in more than 70% of patients from the first years of life. They are well-defined, light to dark brown patches, concentrated on the trunk, neck and skin folds.
  • Patchy hyperpigmentation: Appears on sun-exposed skin or in skin folds, giving a "dirty" or mottled gray-brown look.
  • Hypopigmented macules: Scattered among the darker areas, producing a mottled, poikiloderma-like appearance.
• Skeletal Changes and Birth Defects:
  • Radial ray defects: Hypoplastic or absent thumb, a thumb with an extra joint (triphalangeal thumb), or absent radius.
  • Short stature from birth, small head (microcephaly) and small eyes (microphthalmia).
• Progressive Bone Marrow Failure (BMF):
  • Usually begins between ages 6 and 10, with all three blood cell lines falling: bleeding into the skin and mucous membranes from low platelets; fatigue and pallor from anemia; and repeated infections from low neutrophils.
• Very High Cancer Susceptibility:
  • Blood cancers: High risk of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).
  • Squamous cell carcinoma (SCC): Particularly of the oral mucosa, tongue, esophagus and anogenital region, often in the 20s and 30s. People with FA have a risk of oral SCC hundreds of times higher than the general population.

Diagnostic Workup at Haute-Derma

• Clinical Assessment and Dermoscopy:
  • We count and measure café-au-lait macules and distinguish FA from neurofibromatosis type 1 (NF1 criteria usually require more than 6 large CALMs).
  • Oral mucosal and skin dermoscopy: We look for leukoplakia, non-healing ulcers or unusual rough patches on the tongue and inner cheeks to catch precancerous (actinic/dysplastic) lesions early.
• Chromosome Breakage Test (Gold Standard): Peripheral blood white cells are cultured with a DNA crosslinking agent such as diepoxybutane (DEB) or mitomycin C (MMC). FA cells show chromosome breaks and star-shaped fusions (radial forms) at many times the normal rate.
• Molecular Gene Sequencing (NGS Panel): Identifies the specific mutation in the FANC genes to define the subtype and support family genetic counseling.
• Coordinated Hematology and Imaging Screening:
  • Complete blood count, plus bone marrow aspiration/biopsy to screen for myelodysplasia.
  • Abdominal ultrasound to assess kidney structure (horseshoe kidney or renal agenesis is common).

Treatment and Preventive Care at Haute-Derma

People with Fanconi anemia need especially gentle care that strictly avoids DNA-damaging agents and keeps close watch on cancer risk:

Managing and Restoring the Skin and Mucosal Barrier

• Rigorous sun protection: People with FA are highly vulnerable to UV-induced DNA damage. Daily mineral sunscreen with zinc oxide/titanium dioxide, SPF 50+, PA++++, is required, along with protective clothing and shade.
• Gentle oral care: Use an alcohol-free mouthwash with soothing, naturally antibacterial ingredients (low-concentration HOCl, mucosal hyaluronic acid). Avoid mechanical injury to the mouth lining, such as stiff toothbrushes or spicy, hot or sharp-edged foods.

Critical Warnings for Medical and Cosmetic Procedures

• Radiotherapy and DNA-damaging chemotherapy are contraindicated: FA cells are extremely sensitive to radiation and alkylating agents.
• Ablative lasers and aggressive procedures are contraindicated: Never use ablative CO2 laser, high-power picosecond laser or high-strength chemical peels on FA skin, because the cells cannot repair the resulting DNA damage, which can cause skin necrosis or trigger malignant mutations.

Regular Mucosal and Skin Cancer Screening

• Oral examination every 3–6 months: A dermatologist or clinical dentist carefully checks the entire mouth, throat and tongue. Any ulcer lasting more than 2 weeks or any patch of leukoplakia should be biopsied immediately to rule out SCC.
• Full skin examination every 6 months: Dermoscopy to screen for keratotic lesions, unusual warts or changing pigmented patches.
• Hematology coordination: Blood counts are monitored closely, with immediate referral to a hematology center for bone marrow testing if any cell line starts to fall.